0001939408-22-000001.txt : 20220726 0001939408-22-000001.hdr.sgml : 20220726 20220726155524 ACCESSION NUMBER: 0001939408-22-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220726 DATE AS OF CHANGE: 20220726 EFFECTIVENESS DATE: 20220726 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Leviathan Therapeutics, Inc. CENTRAL INDEX KEY: 0001939408 IRS NUMBER: 882977250 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-453788 FILM NUMBER: 221107032 BUSINESS ADDRESS: STREET 1: 275 SECOND AVE STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 6172037118 MAIL ADDRESS: STREET 1: 275 SECOND AVE STREET 2: SUITE 200 CITY: WALTHAM STATE: MA ZIP: 02451 D 1 primary_doc.xml X0708 D LIVE 0001939408 Leviathan Therapeutics, Inc. 275 SECOND AVE SUITE 200 WALTHAM MA MASSACHUSETTS 02451 6172037118 DELAWARE None None Corporation true 2022 Lauren Mifflin c/o Leviathan Therapeutics, Inc. 275 Second Ave, Suite 200 Waltham MA MASSACHUSETTS 02451 Executive Officer Director Brian Gastman c/o Leviathan Therapeutics, Inc. 275 Second Ave, Suite 200 Waltham MA MASSACHUSETTS 02451 Director Melissa Lokugamage c/o Leviathan Therapeutics, Inc. 275 Second Ave, Suite 200 Waltham MA MASSACHUSETTS 02451 Director Biotechnology Decline to Disclose 06b false 2022-07-22 false true false 0 1000000 250000 750000 false 1 0 0 0 true false Leviathan Therapeutics, Inc. /s/ Lauren Mifflin Lauren Mifflin President 2022-07-26